Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian, fallopian tube and/or primary peritoneal cancer

Jacob P. Hoogendam, Joline F. Roze*, Fleur T. van de Wetering, René Spijker, Leen Verleye, Joan Vlayen, Wouter B. Veldhuis, Rob J P M Scholten, RP Zweemer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To assess the diagnostic test accuracy of PET(-CT), conventional and diffusion-weighted MRI as an replacement or an add-on to abdominal CT, for predicting tumour resectability at primary debulking surgery in patients with stage III - IV epithelial ovarian, fallopian tube and/or primary peritoneal cancer. To investigate the year of study initiation, the annual surgical caseload and whether surgery is performed by a gynaecological oncologist as possible sources of heterogeneity. For further details, please see Investigations of heterogeneity.

Original languageEnglish
Article numberCD012567
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number3
DOIs
Publication statusPublished - 3 Mar 2017

Fingerprint

Dive into the research topics of 'Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian, fallopian tube and/or primary peritoneal cancer'. Together they form a unique fingerprint.

Cite this